Peak inspiratory flows in children with cystic fibrosis

L M Gauld1, K Briggs, P Robinson

  • 1Department of Respiratory Medicine, Royal Children's Hospital, Flemington Road, Parkville, Victoria, Australia. gauldl@cryptic.rch.unimelb.edu.au

Insights

In children with cystic fibrosis lung disease, peak inspiratory flow is generally adequate for dry powder inhalers. However, reduced forced vital capacity may indicate lower peak inspiratory flow, suggesting metered dose inhalers may be more suitable.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Cystic Fibrosis Research

Background:

  • Cystic fibrosis (CF) significantly impacts lung function, potentially affecting inspiratory flow rates.
  • Accurate assessment of inspiratory flow is crucial for effective medication delivery via inhalers in children with CF.

Purpose of the Study:

  • To evaluate if inspiratory flow is reduced in children with moderately severe cystic fibrosis lung disease.
  • To determine if peak inspiratory flow can be predicted using parameters like height, expiratory flow, or body mass index.

Main Methods:

  • Prospective enrollment of children aged >5 years with CF and forced expiratory volume in 1 second <60% predicted.
  • Measurement of height, weight, peak inspiratory flow, forced expiratory volume in 1 second, and forced vital capacity.
  • Application of linear and logistic regression analyses to assess relationships between variables.

Main Results:

  • All studied children demonstrated peak inspiratory flow >0.5 L/s, sufficient for dry powder inhaler activation.
  • Significant correlations were found between peak inspiratory flow and forced vital capacity (R2=0.50), particularly in boys (R2=0.65).
  • Peak inspiratory flow did not correlate with height, age, weight, body mass index, or predicted expiratory flow values.

Conclusions:

  • Children with significant CF lung disease typically maintain adequate peak inspiratory flow for dry powder inhalers.
  • A forced vital capacity <2.5 L may predict a peak inspiratory flow <2.0 L/s, indicating a potential need for metered dose inhalers with spacers.
  • Further research is recommended to explore the relationship between expiratory flow and peak inspiratory flow against internal resistance.
Abstract

Related Concept Videos

Physical Assessment of the Respiratory Tract II: Inspection01:27

Physical Assessment of the Respiratory Tract II: Inspection

Physical assessment of the respiratory tract through inspection is a crucial step in understanding the patient's respiratory health. It provides insights into the functioning of the respiratory system, the musculoskeletal structure, and even the patient's nutritional status. This comprehensive approach involves observing several vital aspects: chest configuration, breathing patterns, respiratory rates, skin color, and use of accessory muscles.
Chest Configuration
The chest configuration can...
Respiratory Volumes and Capacities01:22

Respiratory Volumes and Capacities

The respiratory system is responsible for the intake of oxygen and the expulsion of carbon dioxide from the body. Respiratory volumes describe the volume of air in the lungs at different phases of the respiratory cycle. Tidal volume is the air breathed in and out during normal, quiet breathing. Inspiratory reserve volume is the air that can be forcefully inspired beyond the tidal volume. In contrast, expiratory reserve volume refers to the air that can be expelled from the lungs after a normal...
Respiratory Capacities01:24

Respiratory Capacities

Respiratory capacities are crucial indicators of lung function, representing the maximum amount of air an individual's respiratory system can handle during various breathing phases.
One key metric is the Inspiratory Capacity (IC), which represents the maximum amount of air that can be inhaled with full effort. IC is calculated by summing the tidal volume and inspiratory reserve volume, typically ranging from 2.4 to 3.6 liters.
The Functional Residual Capacity (FRC) represents the air in the...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...